← Open Payments lookup

SARAH OLTMAN: Open Payments

NPI 1255952164 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,375 in 54 payments from 11 companies in 2025. Trend: 2023 $521 · 2024 $172 · 2025 $1,375

Food & beverage: $1,375
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$329
Takeda Pharmaceuticals U.S.A., Inc.7$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$173
Vanda Pharmaceuticals Inc.6$159
ABBVIE INC.5$131
Lundbeck LLC4$114
Teva Pharmaceuticals USA, Inc.4$108
Alkermes, Inc.3$85
Neurocrine BioSciences, Inc.2$58
Collegium Pharmaceutical, Inc.1$24

Products named: REXULTI, TRINTELLIX, CAPLYTA, FANAPT, VRAYLAR, AUSTEDO XR, ARISTADA, INGREZZA.

Industry payments across OR — which companies pay providers there.